References
- Feldman D M, Borgida A F, Rodis J F, Leo M V, Campbell W A. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. Am J Obstet Gynecol 2003; 189: 710–713
- Sherard J, Bean C, Bove B, et al. Long survival in a 69XXY triploid male. Am J Med Genet 1986; 25: 307–312
- Rijhsinghani A, Yankowitz J, Strauss R A, Kuller J A, Patil S, Williamson R A. Risk of preeclampsia in second-trimester triploid pregnancies. Obstet Gynecol 1997; 90: 884–888
- Craig K, Pinette M G, Blackstone J, Chard R, Cartin A. Highly abnormal maternal inhibin and beta-human chorionic gonadotropin levels along with severe HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome at 17 weeks' gestation with triploidy. Am J Obstet Gynecol 2000; 182: 737–739
- Benn P A, Gainey A, Ingardia C J, Rodis J F, Egan J F. Second trimester maternal serum analytes in triploid pregnancies: Correlation with phenotype and sex chromosome complement. Prenat Diagn 2001; 21: 680–686